TY - JOUR
T1 - Heart failure in patients with human immunodeficiency virus infection
T2 - Epidemiology and management disparities
AU - Al-Kindi, Sadeer G.
AU - Elamm, Chantal
AU - Ginwalla, Mahazarin
AU - Mehanna, Emile
AU - Zacharias, Michael
AU - Benatti, Rodolfo
AU - Oliveira, Guilherme H.
AU - Longenecker, Chris T.
N1 - Publisher Copyright:
© 2016 Elsevier Ireland Ltd. All rights reserved.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Background Persons living with HIV are at a higher risk of cardiovascular disease despite effective antiretroviral therapy and dramatic reductions in AIDS-related conditions. We sought to identify the epidemiology of heart failure (HF) among persons living with HIV in the United States in an era of contemporary antiretroviral therapy. Methods Explorys is an electronic healthcare database that aggregates medical records from 23 healthcare systems nationwide. Using systemized nomenclature of medicine - clinical terms (SNOMED - CT), we identified adult patients (age > 18), who had active records over the past year (September 2014-September 2015). We described the prevalence of HF in HIV patients by demographics and treatment and compared them to HIV-uninfected controls. Results Overall, there were 36,400 patients with HIV and 12,208,430 controls. The overall prevalence of HF was 7.2% in HIV and 4.4% in controls (RR 1.66 [1.60-1.72], p < 0.0001). The relative risk of HF associated with HIV infection was higher among women and younger age groups. Patients receiving antiretroviral therapy had only marginally lower risk (6.4% vs. 7.7%, p < 0.0001) of HF compared to those who were untreated. Compared to uninfected patients with HF, HIV patients with HF were less likely to receive antiplatelet drugs, statins, diuretics, and ACE/ARBs (p < 0.0001 for all comparisons). For patients with HIV and HF, receiving care from a cardiologist was associated with higher use of antiplatelets, statins, betablockers, ACE/ARBs, and diuretics. Conclusions Persons with HIV are at higher risk for HF in this large contemporary sample that includes both men and women. Although the prevalence of heart failure is higher in older HIV patients, the relative risk associated with HIV is highest in young people and in women. HIV patients are less likely to have HF optimally treated, but cardiology referral was associated with higher treatment rates.
AB - Background Persons living with HIV are at a higher risk of cardiovascular disease despite effective antiretroviral therapy and dramatic reductions in AIDS-related conditions. We sought to identify the epidemiology of heart failure (HF) among persons living with HIV in the United States in an era of contemporary antiretroviral therapy. Methods Explorys is an electronic healthcare database that aggregates medical records from 23 healthcare systems nationwide. Using systemized nomenclature of medicine - clinical terms (SNOMED - CT), we identified adult patients (age > 18), who had active records over the past year (September 2014-September 2015). We described the prevalence of HF in HIV patients by demographics and treatment and compared them to HIV-uninfected controls. Results Overall, there were 36,400 patients with HIV and 12,208,430 controls. The overall prevalence of HF was 7.2% in HIV and 4.4% in controls (RR 1.66 [1.60-1.72], p < 0.0001). The relative risk of HF associated with HIV infection was higher among women and younger age groups. Patients receiving antiretroviral therapy had only marginally lower risk (6.4% vs. 7.7%, p < 0.0001) of HF compared to those who were untreated. Compared to uninfected patients with HF, HIV patients with HF were less likely to receive antiplatelet drugs, statins, diuretics, and ACE/ARBs (p < 0.0001 for all comparisons). For patients with HIV and HF, receiving care from a cardiologist was associated with higher use of antiplatelets, statins, betablockers, ACE/ARBs, and diuretics. Conclusions Persons with HIV are at higher risk for HF in this large contemporary sample that includes both men and women. Although the prevalence of heart failure is higher in older HIV patients, the relative risk associated with HIV is highest in young people and in women. HIV patients are less likely to have HF optimally treated, but cardiology referral was associated with higher treatment rates.
KW - Abbreviations HIV Human immunodeficiency virus
KW - AIDS Acquired Immunodeficiency Syndrome
KW - ART Antiretroviral Therapy
KW - CAD Coronary Artery Disease
KW - CI Confidence Interval
KW - HF Heart Failure
KW - RR Relative Risk
UR - http://www.scopus.com/inward/record.url?scp=84970939925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84970939925&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.05.027
DO - 10.1016/j.ijcard.2016.05.027
M3 - Article
C2 - 27232910
AN - SCOPUS:84970939925
SN - 0167-5273
VL - 218
SP - 43
EP - 46
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -